Effect of recombinant Lactobacillus expressing canine GM-CSF on immune function in dogs

Journal of Microbiology and Biotechnology

Volumn 19, Issue 11, 2009, Pages 1401-1407

  Chung, Jin Young ^a   Sung, Eui Jae ^a   Cho, Chun Gyu ^a   Seo, Kyoung Won ^a   Lee, Jong Soo ^b   Bhang, Dong Ha ^a   Lee, Hee Woo ^a   Hwang, Cheol Yong ^a   Lee, Wan Kyu ^c   Youn, Hwa Young ^a   Kim, Chul Joong ^d  

^a Seoul National University   (South Korea)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Chungbuk National University   (South Korea)

^d Chungnam National University   (South Korea)

Author keywords

Canine GM CSF; In vitro; In vivo; Lactobacillus casei

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROBIOTIC AGENT; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BODY WEIGHT; CELL COUNT; CONTROLLED STUDY; CORONAVIRUS; DIET SUPPLEMENTATION; DOG; DRUG MECHANISM; GENETIC ENGINEERING; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; LACTOBACILLUS CASEI; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PUPPY; WESTERN BLOTTING;

ADMINISTRATION, ORAL; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; BASE SEQUENCE; BODY WEIGHT; CORONAVIRUS INFECTIONS; CORONAVIRUS, CANINE; DOG DISEASES; DOGS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LACTOBACILLUS CASEI; MOLECULAR SEQUENCE DATA; MONOCYTES; PROBIOTICS; RECOMBINANT PROTEINS; VIRAL VACCINES;

CANIS FAMILIARIS; CORONAVIRUS; LACTOBACILLUS; LACTOBACILLUS CASEI;

EID: 71549142605     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.0904.04010     Document Type: Article

References (34)

1. Amitage, J. O. 1998. Emerging applications of recombinant human granulocyte-macrophage colony-stimulation factor. Blood 92: 4491-4508.
2. Ashiuchi, M., C. Nawa, T. Kamei, J. J. Song, S. P. Hong, M. H. Sung, K. Soda, and H. Misono. 2001. Physiological and biochemical characteristics of poly-γ-glutamate synthetase complex of Bacillus subtilis. Eur. J. Biochem. 268: 5321-5328.
3. Ashiuchi, M., K. Soda, and H. Misono. 1999. A poly-γ-glutamate synthetic system of Bacillus subtilis IFO 3336: Gene cloning and biochemical analysis of poly-γ-glutamate produced by Escherichia coli clone cells. Biochem. Biophys. Res. Commun. 263: 6-12.
4. Benson, E. B. and W. Strober. 1988. Regulation of IgA secretion by T cell clones derived from the human gastrointestinal tract. J. Immunol. 140: 1874-1882.
5. Bermudez-Humaran, L. G., N. G. Cortes-Perez, Y. Le Loir, J. M. Alcocer-Gonzalez, R. S. Tamez-Guerra, R. M. de Oca-Luna, and P. Langella. 2004. An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci. J. Med. Microbiol. 53: 427-433.
6. Borrello, I. and D. Pardoll. 2002. GM-CSF-based cellular vaccines: A review of the clinical experience. Cytokine Growth Factor Rev. 13: 185-193.
7. Christensen, H. R., H. Frokiaer, and J. J. Pestka. 2002. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168: 171-178.
8. Cortes-Perez, N. G., V. Azevedo, J. M. Alcocer-Gonzalez, C. Rodriguez-Padilla, R. S. Tamez-Guerra, G. Corthier, A. Gruss, P. Langella, and L. G. Bermudez-Humaran. 2005. Cell-surface display of E7 antigen from human papillomavirus type-16 in Lactococcus lactis and in Lactobacillus plantarum using a new cell-wall anchor from lactobacilli. J. Drug Target. 13: 89-98.
9. Cortes-Perez, N. G., L. G. Bermudez-Humaran, Y. Le Loir, C. Rodriguez-Padilla, A. Gruss, O. Saucedo-Cardenas, P. Langella, and R. Montes-de Oca-Luna. 2003. Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein. FEMS Microbiol. Lett. 229: 37-42.
10. Fleischmann, J., D. W. Golde, R. H. Weisbart, and J. C. Gasson. 1986. Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. Blood 68: 708-711. (Pubitemid 16008175)
11. Gerritse, K., M. Posno, M. M. Schellekens, W. J. Boersma, and E. Claassen. 1990. Oral administration of TNP-Lactobacillus conjugates in mice: A model for evaluation of mucosal and systemic immune responses and memory formation elicited by transformed lactobacilli. Res. Microbiol. 141: 955-962.
12. Gorbach, S. L. 1990. Lactic acid bacteria and human health. Ann. Med. 22: 37-41.
13. Hammond, W. P., E. Csiba, A. Canin, H. Hockman, L. M. Souza, J. E. Layton, and D. C. Dale. 1991. Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor. J. Clin. Invest. 87: 704-710.
14. Herbst, B., G. Köhler, A. Mackensen, H. Veelken, and A. Lindemann. 1998. GM-CSF promotes differentiation of a precursor cell of monocytes and Langerhans-type dendritic cells from CD34+ haematopoietic progenitor cells. Br. J. Haematol. 101: 231-241.
15. Jeong, K. J., J. H. Choi, W. M. Yoo, K. C. Keum, N. C. Yoo, S. Y. Lee, and M. H. Sung. 2004. Constitutive production of human leptin by fed-batch culture of recombinant rpoS- Escherichia coli. Protein Expr. and Purif. 36: 150-156.
16. Johnson-Henry, K. C., D. J. Mitchell, Y. Avitzur, E. Galindo- Mata, N. L. Jones, and P. M. Sherman. 2004. Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Dig. Dis. Sci. 49: 1095-1102.
17. Kraehenbuhl, J. P. and M. R. Neutra. 1992. Molecular and cellular basis of immune protection of mucosal surfaces. Physiol. Rev. 72: 853-879.
18. Maassen, C. B., W. J. Boersma, C. van Holten-Neelen, E. Claassen, and J. D. Laman. 2003. Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: Implications for vaccine development. Vaccine 21: 2751-2757.
19. Makino, S., I. Uchida, N. Terakado, C. Sasakawa, and M. Yoshikawa. 1989. Molecular characerization and protein analysis of the cap region which is essential for encapsulation in Bacillus anthracis. J. Bacteriol. 171: 722-730. (Pubitemid 19053478)
20. Maliszewski, C. R., M. A. Schoenborn, D. P. Cerretti, J. M. Wignall, K. S. Picha, D. Cosman, R. J. Tushinski, S. Gillis, and P. E. Baker. 1988. Bovine GM-CSF: Molecular cloning and biological activity of the recombinant protein. Mol. Immunol. 25: 843-850.
21. Metcalf, D. 1986. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factor. Blood 67: 257-267. (Pubitemid 16164633)
22. Metcalf, D., A. W. Burgess, G. R. Johnson, N. A. Nicola, E. C. Nice, J. DeLamarter, D. R. Thatcher, and J. J. Mermod. 1986. In vitro actions on hemopoietic cells of recombinant murine GM-CSF purified after production in Escherichia coli: Comparison with purified native GM-CSF. J. Cell. Physiol. 128: 421-431.
23. Morrissey, P. J., L. Bressler, L. S. Park, A. Alpert, and S. Gillis. 1987. Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. J. Immunol. 139: 1113-1119.
24. Nathan, C. 1989. Respiratory burst in adherent human neutrophils. Triggering by colony-stimulating factors CSF-GM and CSF-G. Blood 73: 301-306.
25. Poo, H., H. M. Pyo, T. Y. Lee, S. W. Yoon, J. S. Lee, C. J. Kim, M. H. Sung, and S. H. Lee. 2006. Oral administration of human papillomavirus type 16 E7 displayed on Lactobacillus casei induces E7-specific antitumor effects in C57/BL6 mice. Int. J. Cancer 119: 1702-1709. (Pubitemid 44258780)
26. Pouwels, P. H., R. J. Leer, and W. J. Boersma. 1996. The potential of Lactobacillus as a carrier for oral immunization: Development and preliminary characterization of vector systems for targeted delivery of antigens. J. Biotechnol. 44: 183-192.
27. Robinson, B. E., H. E. McGrath, and P. J. Quesenberry. 1987. Recombinant murine granulocyte-macrophage colony-stimulating factor has megakaryocyte colony stimulating activity and augments megakaryocyte colony stimulation by interleukin 3. J. Clin. Invest. 79: 1648-1652.
28. Schuening, F. G., R. Storb, S. Goehle, R. Nash, T. C. Graham, F. R. Appelbaum, R. Hackman, B. M. Sandmaier, and D. L. Urdal. 1989. Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factor. Exp. Hematol. 17: 889-894.
29. Seegers, J. F. 2002. Lactobacilli as live vaccine delivery vectors: Progress and prospects. Trends Biotechnol. 20: 508-515.
30. Strober, W. 1990. Regulation of IgA B-cell development in the mucosal immune system. J. Clin. Immunol. 10: 56S-61S.
31. Villalta, F. and F. Kierszenbaum. 1986. Effects of human colony-stimulating factor on the uptake and destruction of a pathogenic parasite (Trypanosoma cruzi ) by human neutrophils. J. Immunol. 137: 1703-1707. (Pubitemid 16014827)
32. Wang, J. M., S. Colella, P. Allavena, and A. Mantovani. 1987. Chemotactic activity of human recombinant granulocyte-macrophage colony-stimulating factor. Immunology 60: 439-444.
33. Warren, T. L. and G. J. Weiner. 2000. Uses of granulocyte-macrophage colony-stimulating factor in vaccine development. Curr. Opin. Hematol. 7: 168-173.
34. Weisbart, R. H., L. Kwan, D. W. Golde, and J. C. Gasson. 1987. Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants. Blood 69: 18-21.